Back
Abits Group Vs. Nektar Therapeutics Industry Stock Comparison
Sell
46
ABTS
Abits Group
Last Price:
$4.63
Seasonality Move:
-17.82%
Sell
49
NKTR
Nektar Therapeutics
Last Price:
$24.49
Seasonality Move:
-1.81%
Sell
46
Abits Group (ABTS)
is a Sell
Is Abits Group a Buy, Sell or Hold?
-
The current Abits Group [ABTS] share price is $4.62. The Score for ABTS is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
ABTS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $25.00. The Score for NKTR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ABTS Stock Price Chart
What is Abits Group's stock price today?
-
The Abits Group share price today is $4.62The current trend is moderately bearish and ABTS is experiencing slight selling pressure.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $25.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.
ABTS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.17 | Buy |
Relative Strength Index (14 RSI): | 50.77 | Buy |
Chaikin Money Flow: | -579 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.91 - 5.11) | Buy |
Bollinger Bands (100): | (2.54 - 4.78) | Buy |
NKTR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.99 | Buy |
Relative Strength Index (14 RSI): | 60.52 | Buy |
Chaikin Money Flow: | 338114 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.19 - 28.43) | Buy |
Bollinger Bands (100): | (7.56 - 20.22) | Buy |
ABTS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.79 | Sell |
20-day SMA: | 4.71 | Sell |
50-day SMA: | 4.28 | Buy |
200-day SMA: | 5.68 | Sell |
8-day EMA: | 4.75 | Sell |
20-day EMA: | 4.66 | Sell |
50-day EMA: | 4.35 | Buy |
200-day EMA: | 5.55 | Sell |
NKTR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.95 | Buy |
20-day SMA: | 24.7 | Buy |
50-day SMA: | 16.94 | Buy |
200-day SMA: | 14.86 | Buy |
8-day EMA: | 5.56 | Buy |
20-day EMA: | 2.38 | Buy |
50-day EMA: | 0.98 | Buy |
200-day EMA: | 0.25 | Buy |
Abits Group Earnings Growth & ABTS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.08 per share, an increase this year of $1.99 per share, and a decrease next year of $1.16 per share.
Abits Group Technical Analysis
Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nektar Therapeutics Technical Analysis
Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |